10/29: AMTrack2-Corporate Practice

"You know it don't come easy" - Managing a Crisis: Preparation, Response and Lessons Learned

Moderator:
W. Todd Baker, Kirkland & Ellis, Washington, DC

Drafting Agreements and Licenses - Drafting Arbitration Provisions
Jeremy McKown, Johnson & Johnson, New Brunswick, NJ

How to be a Leader Through a Crisis - the Need for Authenticity and Vulnerability
Coke Morgan Stewart, Regent University School of Law, Virginia Beach, VA

Cultural Competence and Ethics and Rule 1.1. Mental Health and Well Being
Mercedes Meyer, Faegre Drinker Biddle & Reath, Washington, DC

Speakers

• Baker, W. Todd

  Kirkland & Ellis | Partner

  W. Todd Baker is an IP litigation partner in the Washington, D.C., office of Kirkland & Ellis LLP. Todd is experienced handling post-grant matters at the USPTO including all aspects of IPR proceedings at the USPTO's Patent Trial and Appeal Board (PTAB). He advises clients on issues of patentability, derivation, inventorship and priority related to post grant matters before the PTAB as a supplement or an alternative to traditional litigation-based patent validity challenges.
• Stewart, Coke Morgan

  former Acting Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO

  Coke Morgan Stewart is the former Acting Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO. Prior to joining the Regent University School of Law faculty in 2021, Ms. Stewart served as the Acting Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office (USPTO). In that role, Ms. Stewart helped manage one of the largest intellectual property offices in the world and helped oversee the agency’s more than 14,000 employees and $4 billion budget.
• McKown, Jeremy K.

  Johnson & Johnson | Global Patent Head

  Jeremy is the Global Patent Head of Johnson & Johnson’s pharmaceutical business, where he manages a global team of attorneys and professionals focused on creating robust patent portfolios and providing strategic counsel to its’ Innovative Medicine companies. In addition, he advises on material R&D transactions and IP litigations, and actively works with external trade associations to ensure we have meaningful IP policies. Previously, he led the R&D Legal team responsible for drafting and negotiating complex agreements for J&J’s Innovative Medicine companies.
• Meyer, Mercedes K.

  Banner Witcoff | Attorney

  Mercedes Meyer, Ph.D., represents leading life science and technology companies maintaining an extensive biotechnology and pharmaceutical patent management, prosecution, opinion and due diligence practice. With a doctorate in virology and degree in chemistry, Mercedes has a deep understanding of complex biotechnology and scientific research, which is key for advising life science clients on commercializing and protecting product innovations as well as performing diligence for investing in new technologies, particularly in corporate joint development projects. Mercedes advises on developing patent strategies, managing the intellectual property rights, and making associated investments and acquisitions. Mercedes also handles patent reexaminations and inter partes matters.